Evaluation of effectiveness of plasma lyso-Gb3 analogues as biomarker for diagnosing of Fabry disease
Not Applicable
- Conditions
- Fabry disease
- Registration Number
- JPRN-UMIN000036465
- Lead Sponsor
- Department of Clinical Nephroscience, Niigata University Graduate School of Medical and Dental Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients have pathogenic GLA mutation and already diagnosed as Fabry disease should be excluded.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method